Salmeterol
Back to searchMolecule Structure
Scientific Name
Salmeterol
Description of the Drug
Salmeterol is a long-acting beta-2 adrenergic receptor agonist used to treat asthma and COPD.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00938
http://www.drugbank.ca/drugs/DB00938
Brand Name(s)
Beglan, Neovent, Serevent, Soltel, Vertine
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Glaxosmithkline, Hikma Pharmaceuticals Usa Inc, Glaxo Group Ltd England Dba Glaxosmithkline, Mylan Pharmaceuticals Inc, Glaxosmithkline Intellectual Property Ltd England, Teva Pharmaceutical Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4767 | |||||
| PharmGKB | PA451300 | |||||
| Human Metabolome Database | HMDB0015073 | |||||
| DrugBank | DB00938 | |||||
| PubChem: Thomson Pharma | 14904552 | |||||
| PubChem | 5152 | |||||
| LINCS | LSM-1240 | |||||
| Nikkaji | J707.866H | |||||
| BindingDB | 25771 | |||||
| EPA CompTox Dashboard | DTXSID6023571 | |||||
| DrugCentral | 2419 | |||||
| Brenda | 145995 | 55895 | 145081 | |||
| ChemicalBook | CB42622471 | CB12621448 | CB52623293 | CB32545735 | CB9186866 | CB83050596 |
| Guide to Pharmacology | 559 | |||||
| rxnorm | SALMETEROL XINAFOATE | SEREVENT | SALMETEROL | |||
| KEGG Ligand | C07241 | |||||
| ChEBI | 64064 |
